Mandate

Vinge advises Semcon in connection with the offer by Ratos

September 26, 2022 Capital Markets and Public M&A

Vinge is advising Semcon AB (publ) due to the fact that Ratos AB has provided a competing recommended cash offer to the shareholders of Semcon.

The offer price is for SEK 157 per share, which values Semcon at approximately SEK 2 844 million in total.

Vinge’s team primarily consists of Anders Strid, Erik Sjöman and Edin Agic as well as Anna Palmérus who is advising Semcon in relation to competition law issues.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025